Hbk Sorce Advisory LLC Biogen Inc. Transaction History

Hbk Sorce Advisory LLC

$2.69 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$222.59 - $267.94 $92,820 - $111,730	-417 Reduced 33.96%	811 $209,000
Q3 2023 Nov 06, 2023	BUY	$253.3 - $285.89 $103,599 - $116,929	409 Added 49.94%	1,228 $315,000
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $221,301 - $255,720	-804 Reduced 49.54%	819 $233,000
Q1 2023 Aug 15, 2023	BUY	$256.56 - $292.34 $513 - $584	2 Added 0.24%	821 $228,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $5,387 - $6,139	-21 Reduced 1.28%	1,623 $680,000
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $208,010 - $252,737	824 Added 100.49%	1,644 $455,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $159,645 - $220,137	820 New	820 $219,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $351,305 - $442,625	-1,813 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $63,145 - $81,151	-282 Reduced 13.46%	1,813 $435,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $5,093 - $6,642	-18 Reduced 0.85%	2,095 $593,000
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $78,736 - $126,071	304 Added 16.8%	2,113 $732,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $25,509 - $29,886	-105 Reduced 5.49%	1,809 $506,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $184,046 - $277,035	779 Added 68.63%	1,914 $469,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $529 - $611	-2 Reduced 0.18%	1,135 $322,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $8,018 - $10,619	-31 Reduced 2.65%	1,137 $304,000
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $3,226 - $4,092	12 Added 1.04%	1,168 $370,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $1,956 - $2,194	-9 Reduced 0.77%	1,156 $269,000
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $266,218 - $293,448	-1,214 Reduced 51.03%	1,165 $272,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $248,894 - $274,352	1,135 Added 91.24%	2,379 $575,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $329,399 - $515,219	-1,520 Reduced 54.99%	1,244 $294,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $72,410 - $91,715	260 Added 10.38%	2,764 $832,000
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $79,834 - $104,401	272 Added 12.19%	2,504 $885,000
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $5,407 - $6,445	21 Added 0.95%	2,232 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $43,961 - $62,176	-169 Reduced 7.1%	2,211 $605,000
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $35,378 - $39,626	115 Added 5.08%	2,380 $758,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $636,804 - $746,747	2,265	2,265 $709,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account